The largest database of trusted experimental protocols

Vaccin

Vaccins are biological preparations that provide active acquired immunity to a particular disease.
They typically contain weakened or killed forms of a pathogen, its toxins, or one of its surface proteins, which stimulate the body's immune system to recognize the agent as a threat, destroy it, and create immunological memory that can quickly eliminate the pathengen upon future exposure.
Vaccines are essential for preventing the spread of infectious diseases and safeguarding public health.

Most cited protocols related to «Vaccin»

Web queries submitted to the web site Vårdguiden.se (www.vardguiden.se) were analysed. The web site is written in Swedish, thus the submitted queries are (mostly) in Swedish. Although the site is accessible by anybody, the primary users are residents in the Stockholm County [18] . However, as no information on the users submitting the queries was available, the data were aggregated on a national level. In the described study, we used Vårdguiden logs from June 27, 2005 to June 24, 2007, thus covering two influenza seasons. No spelling corrections were considered (these are provided by the search engine), nor did we remove possible duplicate searches where a user had submitted a query more than once. All queries were case-folded (that is, turned into lower case). The data were aggregated by week, which is the aggregation level for the sentinel and the laboratory reports. There were logs missing for in total five weeks during the summer of 2006, a period normally not affected by influenza in the northern hemisphere.
Two sets of reference data were used: the number of laboratory verified influenza cases and the proportion of patients with influenza-like illness having seen any of the sentinel general practitioners (GPs) in Sweden. The influenza season normally lasts from the end of November to mid April, with a peak sometime in February/March for most seasons. The reporting is done from October (week number 40) to May (week number 20).
In total, twenty types of queries were included in the statistical analysis. For examples of each type, see Table 1. More specifically, the analysis was performed on queries containing the word influensa (influenza in Swedish) in various variants and on queries on symptoms for influenza-like illness. The seven investigated symptoms were: fever, headache, myalgia, cough, sore throat, coryza, and shortness of breath. These symptoms were motivated by the following ILI-definition:
This definition is based on the ECDC definition, but adapted to the data source, where “sudden onset” is difficult to identify. Also the ECDC definition is supposed to be used by a doctor, while such a person normally is not involved in the formulation of the web queries.
We further counted influenza matches cleaned from queries on items not related to ordinary influenza, counting only queries not containing the Swedish words vaccin (vaccine), fågel (bird), or maginfluensa (stomach flu). Nineteen per cent of the queries matching influenza were on stomach flu, why we also specifically included this query in the examined set. As for the queries on symptoms, in addition to counting these when being the only submitted word, we counted the number of queries matching the ILI definition given above, allowing for other terms in the query. The two most frequently occurring symptoms of the ILI-symptoms (fever and cough), were also investigated when occurring in any constellation. (The Swedish word for cough (hosta) loses its a when being the first element in a compound. This is accounted for in the program counting the occurrence.) Additionally, we examined the term cold (förkylning). All selected query terms consist of one word in Swedish. This is worth noting as about 75 per cent of the queries contain a single term only (Swedish is rich in compounding, and the Swedish equivalence to, for example, influenza vaccine is influensavaccin).
Since the usage of the search engine on Vårdguiden.se increases over time, data were standardised by dividing the counts during one season by the total number of queries to the web site during that particular season. The calculated numbers for the different types of Vårdguiden.se queries were highly correlated, which poses a problem for regular regression due to colinearity issues. Therefore, partial least squares regression (PLSR), which is an approach designed for these kinds of data, was used to generate our estimating models. This is a method used in many application areas for multivariate, highly correlated data [19] . PLSR works by “relating two data matrices, X and Y, to each other by a linear multivariate model” [20, p71] . This is done by using an algorithm closely related to Principal Component Analysis, to transform a highly dependent set of input data into a set of independent components.
The entire PLSR procedure runs as follows (see also Figure 1): Given a set of outcome variables (Y) and a set of input variables (X) it creates new variables (“components”) by adding together the input variables in X, with individual weights for each variable. This is done as many times as there are input variables, with a different set of weights each time. The weights are chosen in such a way that a newly created component exhibits as much as possible of the variation in input and output data that has not been included in previous components. Thus, the first component to be created describes most of the variation in the data, the second describes a little less, and so on. The weights are also chosen so that each component is independent from the others, that is, a single component can not be described as the sum of the other components. Subsequently, the created components are used as input variables for a set of ordinary regressions predicting Y, with increasing number of components included. Finally, the models are validated, in order to establish the number of components to include. The model which exhibits the best validation performance is chosen as the final model. In our analysis the PLSR was applied by using the wide kernel algorithm, as implemented in the PLS package [21] in R 2.6.1 [22] .
The sentinel and the laboratory values from both seasons were used as input variables to two different models, one model for each source, where both used all twenty types of queries as predictor variables.
In our experiments, we used cross validation [23] to find the optimal number of components to include in the models. Briefly, cross validating a model is done by first splitting the data set into a number of equally sized partitions. One partition is then omitted, while the remaining partitions are used to estimate a model. This model is subsequently used to predict the omitted data. Thereafter the difference between the true and the predicted value is measured. This process is repeated multiple times with different partitions omitted. Finally, all obtained differences are squared and averaged to generate an estimate of the precision of the cross validated model. We thus get the mean predictive error. When only one observation is omitted, the process is referred to as leave-one-out cross validation.
We conducted a number of different cross validations, where the number of partitions that the data was split into was varied, from two up to 60. In addition, we tested the extreme case, where only one week was omitted at a time. In the presented research, the omission was done sequentially, that is, we first omitted the first n weeks, then the second n weeks and so on. The resulting 60 different mean predictive errors were used to select the optimal model.
Full text: Click here
Publication 2009

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2021
Coronavirus COVID-19 Vaccines COVID 19 Immunization Vaccination
The selection criteria was jointly decided and agreed by the two reviewers based on the study objective. This research is limited to studies that used intervention mapping in disease-specific prevention interventions, as shown in Table 2.
The PRISMA guidelines for reporting systematic reviews was followed to allow for systematic reporting. The PRISMA checklist is shown as File A in S1 Supporting Information.[9 (link)] Search for published literature was conducted in three main electronic databases: MEDLINE, EMBASE and Web of Science. It was initially designed using MEDLINE on 8th August 2014 and then adapted to the other databases on the same date using their specific terms. This allowed for testing of precision and sensitivity. The Campbell Collaboration and the Cochrane Library were also searched for any available and/or on-going systematic reviews on the topic. Search for grey literature (mainly unpublished research) was carried out on the following databases: OpenGrey and NYAM Grey Literature Report.
A very broad search was initially conducted, which aimed at identifying all intervention mapping studies on health promotion and disease prevention programmes. The titles and abstracts of all the identified studies were read to select those that used intervention mapping in disease-specific prevention interventions. After going through series of modifications, two main search categories were identified; “intervention mapping” related and “disease prevention” related. This gave the broadest search that captured all the relevant studies. The choice of disease prevention related terms was guided by a listing of areas of health promotion that intervention mapping has been applied, as stated on the intervention mapping website.[10 ] However, this underwent a series of iterative process leading to modifications as recommended in the PRISMA guidelines.[11 ] The Boolean operators AND/OR and truncation were used to link words and to identify all the possible endings of the search terms respectively as shown below:
Intervention mapping AND (HIV OR human immunodeficiency virus OR AIDS OR acquired immune deficiency syndrome OR hepatitis B virus OR HBV OR human papilloma virus OR HPV OR chlamydia OR influenza OR infect* OR injur* OR breast cancer OR cervical cancer OR prostate cancer OR colon cancer OR cancer OR drug* OR sex* OR smoking OR cigarette OR alcohol OR drinking OR binge OR wine OR bear OR behavi#r OR physical activity OR exercise OR sedentary OR inactivity OR psychiatr* OR psycholog* OR mental OR fruit OR vegetable OR diet OR nutrition* OR eat* OR feed* OR low calorie* OR low energy OR low fat OR low salt OR obes* OR weight gain OR overweight OR worker* OR student* OR depress* OR dementia OR stress OR chronic disease OR diabetes OR hypertension OR vaccin* OR stroke OR disabilit* OR asthma OR gynecolog* OR health promotion OR health education OR prevention OR ehealth OR family-based OR family OR school-based OR school OR web-based OR workplace OR work related).
Both indexed and free-text terms for intervention mapping were searched for. Details of the search strategy are attached as File B in S1 Supporting Information.
Full text: Click here
Publication 2017
For this study, Scopus search engine was chosen to retrieve required literature. Scopus was used because of its advantages over other databases such as Web of Science (WoS), Google scholar or Pubmed [32 (link)]. According to Falagas et al. study, no database is perfect and each has certain merits over the other. For example, PubMed and Google Scholar are free to use in contrast to Scopus and WoS. PubMed lacks citation analysis in contrast to other databases. Scopus offers about 20% more coverage than Web of Science and 100% of Medline database is covered by Scopus. Google Scholar is the largest in terms of coverage but results obtained by Google Scholar have inconsistent accuracy. Although Scopus covers a wider journal range, it is currently limited to articles published after 1995 when compared with WoS [32 (link)]. In the current study, we preferred the use of Scopus because of its wider coverage since we are interested in global research activity in the eight emerging pathogens. Many of the journals published from developing countries, where these infectious diseases were found, are indexed in Scopus. This is reflected in the number of journals covered by Scopus versus those covered by WoS [32 (link)].
In the current study, keywords used were the names of diseases that appeared in the WHO top eight list. To avoid errors, the names of diseases were followed by conditional keywords such as “virus OR viral OR fever OR hemorrhagic OR haemorrhagic OR corona* OR coronavirus OR infection OR infectious). Fig. 1 illustrates the steps followed along with keywords and search query used in Scopus to retrieve required data.

Strategy and search query used to retrieve required data in Scopus

The data obtained were refined using the side functions in Scopus. Such functions include: 1) time limitation which was set for this study from 1996 to 2015, 2) source type of data which was set in this study to be journal articles while books and book chapters were excluded, and finally 3) type of documents and for the purpose of this study all types of documents were included except errata (correction).
Analysis of data was carried out using the “analyze” function in Scopus menu bar. Analysis included annual number of published documents, productivity of each country, author, preferred journals for publishing research on top eight emerging pathogens, geographical distribution, network visualization, and institution/organization. Scopus allows for citation analysis such as total number of citations, Hirsch index (h-index), and top cited articles. The h-index is a parameter used to measure productivity and scientific impact of an author, institution, or country, or even a subject area [33 (link)]. Scopus can also give analysis about active journals in publishing articles on studied diseases. Active journals were presented along with Impact Factor (IF) which was obtained from the Journal Citation Report published by Thomson Reuters.
An important feature in Scopus is that it allows exclusion or limitation which allow researchers to identify articles published by a single author or a single country. Based on this, we divided articles into two types: (1) single country publications (SCP) in which all authors have the same country affiliation and such publications represent an intra-country collaboration, and (2) multiple country publications (MCP) in which authors have different country affiliation and such publications represent inter-country collaboration.
In bibliometric studies, not all data can be presented. In most bibliometric studies, active or most productive countries, authors, institutions/organizations, and journals are usually presented. In this study, with large number of retrieved documents, only countries, authors, institutions, and journals with a minimum productivity of 100 documents were presented and ranked. The cutoff point of 100 publications have been previously used in other bibliometric studies [34 ]. For analysis pertaining to each infectious disease, only the top 10 productive countries were presented.
An important preventive aspect of most serious infectious diseases is the development of vaccines for prevention of spread. In this study, publications pertaining to vaccine development against any one of the top eight emerging pathogens were sought and presented. The search query used to search for vaccine development was the same search query used to retrieve publications on the top eight pathogens plus the keyword “vaccin*” with an asterisk to retrieve words such as vaccine or vaccination. The complete search query for vaccine data was presented in Fig. 1.
Statistical Package for Social Sciences (SPSS - 21) was used to create graphs pertaining to growth of publications for each disease. Mean ± standard deviation (SD) and median (Q1 – Q3) were used for descriptive statistics. Finally, bibliometric studies do not involve human or animal subjects and therefore, no ethical approval by Institutional Review Board was required.
Full text: Click here
Publication 2017
Animals Communicable Diseases Coronavirus Infections Ethics Committees, Research Fever Hemorrhage Homo sapiens Infection pathogenesis Vaccination Vaccines Virus

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2021
cDNA Library Coronavirus COVID-19 Vaccines COVID 19 Immunization Lymphadenopathy Mammography Scan, CT PET Severe acute respiratory syndrome-related coronavirus Ultrasonography Vaccination

Most recents protocols related to «Vaccin»

Two reviewers (KSK, JDL) searched PubMed and Scopus library databases from inception until January 2023 independently. The search included the following terms: “(COVID 19 vaccin* OR SARS-COV2 vaccin*) AND (minimal change disease OR glomerulonephritis OR nephrotic OR nephritic)”. There were no limitations placed regarding study design, geographic region, or language. Additionally, a manual search of references cited in the included articles and relevant published reviews was conducted to identify any missed studies. Discrepancies during the literature search were resolved by a third investigator (DS).
Full text: Click here
Publication 2024
First, we searched six databases systematically (i.e., MEDLINE, EMBASE, Global Health, EconLit via Ovid, Web of Science, Scopus) in November 2021, using keywords and related MeSH terms and subject headings pertaining to global health partnerships and vaccines: (global public private partnership* or global health partnership* or global health initiative* or public private cooperation* or public private partnership* or public private sector cooperation* or public private sector partnership* or public private alliance* or private finance initiative* or product development partnership* or project finance*) AND (vaccin* or immuni* or immunization programs/ or vaccination coverage/).
We simultaneously conducted an iteratively refined Google Scholar search based on terms related to ‘public-private partnerships’ and ‘vaccines.’ We updated the database and Google Scholar searches in May 2023 to capture recent publications. Lastly, we backward-searched references of eligible articles [17 ].
Full text: Click here
Publication 2024

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2024
We will use the “evidence-based manual for Peer Analysis of Electronic Search Strategies (PRESS 2015)” for systematic searches McGowan et al. [16 (link)] to inform the search approach [16 (link)]. The review question will be divided into concepts and keywords within each concept will be identified. The eligible studies will be searched by using a combination of the following keywords in the databases “HPV vaccine,” “HPV vaccination,” “implementation,” South Asia,” “Gardasil,” “Cervarix,” “Human papillomavirus vaccin*,” “Uptake,” “Scaleup,” and the names of countries within South Asia. Boolean operators AND/OR will be used to combine keywords. Search will be limited to English language articles only. A thorough search of numerous databases, including PubMed, CINAHL, EMBASE, Web of Science, and Scopus, will be used to find relevant literature. An overview of the electronic search for one of the selected databases (PubMed) as a reference have been enclosed in Annexure 2. More potentially qualifying articles will be retrieved by searching the reference lists of included papers. Data will be managed using Rayyan software [17 (link)].
Full text: Click here
Publication 2024
PubMed and Scopus databases were searched independently by MA and AKT using the following keywords: (COVID-19 OR SARS-CoV-2 OR coronavirus) AND (vaccin* OR immunization* OR immunisation*) AND (hesitan* OR reluct* OR refus* OR accept* OR willing* OR intent* OR intend* OR reject* OR delay*) AND (Algeria OR Bahrain OR Comoros OR Djibouti OR Egypt OR Iraq OR Jordan OR Kuwait OR Lebanon OR Libya OR Mauritania OR Morocco OR Oman OR Palestine OR Qatar OR Saudi OR Somalia OR Sudan OR Syria OR Tunisia OR Emirates OR Yemen OR Arab*). The title and abstract screening process was performed by MA and AKT. Disagreements were handled via a discussion with the other study authors. All quantitative cross-sectional studies that assessed COVID-19 vaccine hesitancy and/or acceptance among HCWs in Arab countries up till July 25, 2022, were included. Qualitative (interview-based) studies and studies that included both HCWs along with the general public or students at schools of health sciences without reporting subgroup findings of HCWs were excluded.
Full text: Click here
Publication 2024

Top products related to «Vaccin»

Lumpyvax is a laboratory diagnostic tool developed by MSD Animal Health. It is designed to assist in the detection and identification of certain animal health conditions. The core function of Lumpyvax is to provide accurate and reliable data to support veterinary professionals in their diagnostic and treatment decisions. Further details on the intended use of this product are not available at this time.
Sourced in United States, Japan
Sulfo-NHS-Biotin is a bifunctional reagent that can be used to label proteins and other biomolecules with biotin. It contains an N-hydroxysulfosuccinimide (sulfo-NHS) ester group that can react with primary amines on the target molecule, and a biotin group that can be used for detection or purification using streptavidin or avidin-based methods.
Sourced in United States, Norway, China, France, Germany, Japan
Dynabeads M-280 Streptavidin are uniform superparamagnetic beads coated with streptavidin, a protein that binds strongly to biotin. They are designed for efficient isolation and purification of biotinylated molecules, such as nucleic acids, proteins, and cells.

More about "Vaccin"

Vaccines are a vital component of public health and disease prevention.
These immunological preparations, also known as immunizations or jabs, contain weakened or inactivated forms of pathogens, their toxins, or surface proteins.
When introduced into the body, they stimulate the immune system to recognize and eliminate the target agent, creating a memory that can rapidly respond to future exposures.
This process of active acquired immunity is essential for safeguarding against the spread of infectious diseases.
Vaccines come in various forms, including live-attenuated vaccines (e.g., measles, mumps, and rubella), inactivated vaccines (e.g., polio and hepatitis A), subunit vaccines (e.g., hepatitis B and human papillomavirus), and conjugate vaccines (e.g., pneumococcal and meningococcal).
The specific type of vaccine depends on the pathogen and the desired immune response.
Beyond traditional vaccines, novel approaches such as mRNA vaccines (e.g., Comirnaty and Spikevax) and DNA vaccines are emerging, leveraging advancements in biotechnology.
These innovative solutions harness the power of genetic material to elicit an immune response, offering new possibilities for vaccine development and disease prevention.
Vaccine research and development are crucial endeavors, requiring rigorous testing and evaluation to ensure safety and efficacy.
Tools like Lumpyvax, a bioinformatics platform for vaccine design, and Sulfo-NHS-Biotin, a chemical linker used in vaccine formulations, play important roles in the vaccine development process.
Additionally, Dynabeads M-280 Streptavidin, magnetic beads used for protein purification, can contribute to the production and purification of vaccine components.
As the world continues to face evolving health challenges, the importance of vaccines in maintaining public health and preventing the spread of infectious diseases cannot be overstated.
By understanding the science behind vaccines and the advancements in this field, we can work towards a healthier and more resilient future.